Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial

doi:10.3748/wjg.v10.i24.3634

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4922)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

487

HTML

3969

Figures (1-2)

235

Tables (1-5)

231

Sum=4922

Dec 15, 2004 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (83)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 15, 2004; 10(24): 3634-3638
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3634

Full Size Figure Download Figure

Figure 2 Immunohistochemical staining of Ad5 capsid from the fine-needle aspiration of the tumor tissue injected with H101 at the end of treatment cycle. The dark-brown stained granules (arrows in A) represent a positive staining indicating adenovirus replication and package in the tumor cells. However negative staining was also obtained in one of the three samples (B).

Citation: Lu W, Zheng S, Li XF, Huang JJ, Zheng X, Li Z. Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial. World J Gastroenterol 2004; 10(24): 3634-3638
URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3634.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i24.3634